Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on October 1, 2026

Oct. 1, 2026

AONN+ and Manta Cares Partner to Equip Oncology Navigators With AI Tool Purpose-Built for Cancer Patients

Indeterminate GlobeNewswire

Oct. 1, 2026

Legato Frames, the World’s First AI-Based Hearing Glasses, Are Now Available in the U.S.

Indeterminate GlobeNewswire

Oct. 1, 2026

Vima Therapeutics to Present New Research at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

Oct. 1, 2026

Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma

Indeterminate GlobeNewswire

Oct. 1, 2026

Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)

Indeterminate GlobeNewswire

Oct. 1, 2026

Carlsmed Appoints Tony Jarc as Chief Product and AI Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

Nox Peptides Announces Expanded Research Focus on BPC-157 and GHK-Cu in Canada

Indeterminate GlobeNewswire

Oct. 1, 2026

PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities

Indeterminate GlobeNewswire

Oct. 1, 2026

Health-ISAC® Director of European Operations Elected European Council of ISACs Chair

Indeterminate GlobeNewswire

Oct. 1, 2026

Ο Διευθυντής Ευρωπαϊκών Επιχειρήσεων του Health-ISAC® εξελέγη Πρόεδρος του Ευρωπαϊκού Συμβουλίου ISAC

Indeterminate GlobeNewswire

Oct. 1, 2026

Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya

Indeterminate GlobeNewswire

Oct. 1, 2026

SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress

Indeterminate GlobeNewswire

Oct. 1, 2026

ViroMissile Completes First Dose Cohort of Phase I Trial of Intravenously-Dosed IDOV-2; Safety Review Committee Clears Advancement to Next Cohort

Indeterminate GlobeNewswire

Oct. 1, 2026

RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire

Oct. 1, 2026

TOMI Environmental Solutions Expands SteraMist iHP into India's Pharmaceutical Market Through Partner STS Technocrat (India) Pvt. Ltd.

Indeterminate GlobeNewswire

Oct. 1, 2026

Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation

Indeterminate GlobeNewswire

Oct. 1, 2026

Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet

Indeterminate GlobeNewswire

Oct. 1, 2026

Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers

Indeterminate GlobeNewswire

Oct. 1, 2026

Medicana Highlights Robotic Prostate Surgery as 2026 Review Reports Recovery Benefits

Indeterminate GlobeNewswire